# A Study to Evaluate Symlin in Adolescent Subjects With Type 1 Diabetes Mellitus

> **NCT00313183** · PHASE2 · COMPLETED · sponsor: **AstraZeneca** · enrollment: 12 (actual)

## Conditions studied

- Type 1 Diabetes Mellitus

## Interventions

- **DRUG:** pramlintide acetate

## Key facts

- **NCT ID:** NCT00313183
- **Lead sponsor:** AstraZeneca
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-04
- **Primary completion:** 2007-08
- **Final completion:** 2007-08
- **Target enrollment:** 12 (ACTUAL)
- **Last updated:** 2015-03-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00313183

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00313183, "A Study to Evaluate Symlin in Adolescent Subjects With Type 1 Diabetes Mellitus". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT00313183. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*